Drug Acquisition, For Exemption From Bidding, For The Purpose Of Complying With Judicial Decisions Given, In The Face Of The State Of Rio Grande Do Norte: Atropine Sulfate, Dosage: 0.5 % Mg/Ml, Use: Ophthalmic Solution X 5 Ml; Enzyme, Type: Alpha Glycosidase, 50 Mg Po Liof Solo Inj Iv Ct Fa V Vd Trans Trans Type Or Equivalent; Evolocumab, Concentration: 140 Mg, Ml, Pharmaceutical Form: Injectable Solution, Additional: C, Applicator Pen - Repatha. *

Secretaria Estadual de Saude Publica Brazil has Released a tender for Drug Acquisition, For Exemption From Bidding, For The Purpose Of Complying With Judicial Decisions Given, In The Face Of The State Of Rio Grande Do Norte: Atropine Sulfate, Dosage: 0.5 % Mg/Ml, Use: Ophthalmic Solution X 5 Ml; Enzyme, Type: Alpha Glycosidase, 50 Mg Po Liof Solo Inj Iv Ct Fa V Vd Trans Trans Type Or Equivalent; Evolocumab, Concentration: 140 Mg, Ml, Pharmaceutical Form: Injectable Solution, Additional: C, Applicator Pen - Repatha. * in Pharmaceuticals. The tender was released on May 27, 2025.

Country - Brazil

Summary - Drug Acquisition, For Exemption From Bidding, For The Purpose Of Complying With Judicial Decisions Given, In The Face Of The State Of Rio Grande Do Norte: Atropine Sulfate, Dosage: 0.5 % Mg/Ml, Use: Ophthalmic Solution X 5 Ml; Enzyme, Type: Alpha Glycosidase, 50 Mg Po Liof Solo Inj Iv Ct Fa V Vd Trans Trans Type Or Equivalent; Evolocumab, Concentration: 140 Mg, Ml, Pharmaceutical Form: Injectable Solution, Additional: C, Applicator Pen - Repatha. *

Deadline - Jun 06, 2025

GT reference number - 109715992

Product classification - Medicinal products for the alimentary tract and metabolism